Terms: = Leukemia AND TFEB, TCFEB, 7942, ENSG00000112561, P19484, AlphaTFEB AND Treatment
2 results:
1. A lysosome-targeted dextran-doxorubicin nanodrug overcomes doxorubicin-induced chemoresistance of myeloid leukemia.
Zeng Y; Zhang X; Lin D; Feng X; Liu Y; Fang Z; Zhang W; Chen Y; Zhao M; Wu J; Jiang L
J Hematol Oncol; 2021 Nov; 14(1):189. PubMed ID: 34749790
[TBL] [Abstract] [Full Text] [Related]
2. Reducing FASN expression sensitizes acute myeloid leukemia cells to differentiation therapy.
Humbert M; Seiler K; Mosimann S; Rentsch V; Sharma K; Pandey AV; McKenna SL; Tschan MP
Cell Death Differ; 2021 Aug; 28(8):2465-2481. PubMed ID: 33742137
[TBL] [Abstract] [Full Text] [Related]
